申请人:SANKYO COMPANY LIMITED
公开号:EP0885891A1
公开(公告)日:1998-12-23
The isoxazole derivatives having the following general formula:
[wherein R1 represents an optionally substituted aryl group or aromatic heterocyclic group; R2 represents a hydrogen atom, a halogen atom, an optionally substituted alkyl group, an alkenyl group, an alkynyl group, a cycloalkyl group, a cycloalkenyl group, an alkoxy group, a cyano group, a carboxyl group, an alkanoyl group, an alkoxycarbonyl group or an optionally substituted carbamoyl group; R3 represents an optionally substituted amino group or a saturated heterocyclic group; X represents an oxygen atom or a sulfur atom; n is an integer of from 2 to 6] has an excellent monoamine oxidase inhibitory activity, and is useful as a therapeutic agent or a preventive agent against nervous diseases such as depression.
具有以下通式的异噁唑衍生物:
[其中 R1 代表任选取代的芳基或芳香杂环基团;R2 代表氢原子、卤素原子、任选取代的烷基、烯基、炔基、环烷基、环烯基、烷氧基、氰基、羧基、烷酰基、烷氧羰基或任选取代的氨基甲酰基;R3 代表任选取代的氨基或饱和杂环基团;X 代表氧原子或硫原子;n 为 2 至 6 的整数]具有极佳的单胺氧化酶抑制活性,可用作治疗剂或预防剂,防治抑郁症等神经疾病。